...
首页> 外文期刊>Chemistry: A European journal >Enzyme-Responsive Intracellular-Controlled Release Using Silica Mesoporous Nanoparticles Capped with ?-Poly-L-lysine
【24h】

Enzyme-Responsive Intracellular-Controlled Release Using Silica Mesoporous Nanoparticles Capped with ?-Poly-L-lysine

机译:酶介导的细胞内控释使用二氧化硅介孔纳米粒子与α-聚-L-赖氨酸加帽

获取原文
获取原文并翻译 | 示例

摘要

The synthesis and characterization of two new capped silica mesoporous nanoparticles for controlled delivery purposes are described. Capped hybrid systems consist of MCM-41 nanoparticles functionalized on the outer surface with polymer ?-poly-L-lysine by two different anchoring strategies. In both cases, nanoparticles were loaded with model dye molecule [Ru(bipy)_3]~(2+). An anchoring strategy involved the random formation of urea bonds by the treatment of propyl isocyanate-functionalized MCM-41 nanoparticles with the lysine amino groups located on the ?-poly-L-lysine backbone (solid Ru-rLys-S1). The second strategy involved a specific attachment through the carboxyl terminus of the polypeptide with azidopropyl-functionalized MCM-41 nanoparticles (solid Ru-tLys-S1). Once synthesized, both nanoparticles showed a nearly zero cargo release in water due to the coverage of the nanoparticle surface by polymer ?-poly-L-lysine. In contrast, a remarkable payload delivery was observed in the presence of proteases due to the hydrolysis of the polymer's amide bonds. Once chemically characterized, studies of the viability and the lysosomal enzyme-controlled release of the dye in intracellular media were carried out. Finally, the possibility of using these materials as drug-delivery systems was tested by preparing the corresponding ?-poly-L-lysine capped mesoporous silica nanoparticles loaded with cytotoxic drug camptothecin (CPT), CPT-rLys-S1 and CPT-tLys-S1. Cellular uptake and cell-death induction were studied. The efficiency of both nanoparticles as new potential platforms for cancer treatment was demonstrated.
机译:描述了用于控制递送目的的两种新的封端的二氧化硅介孔纳米粒子的合成和表征。封端的杂化系统由MCM-41纳米粒子组成,该纳米粒子通过两种不同的固定策略在外表面用聚合物α-聚-L-赖氨酸官能化。在这两种情况下,纳米颗粒均装有模型染料分子[Ru(bipy)_3]〜(2+)。锚定策略涉及通过处理异氰酸丙基官能化的MCM-41纳米粒子,其中赖氨酸氨基位于α-聚-L-赖氨酸骨架上(固体Ru-rLys-S1),随机形成脲键。第二种策略涉及通过多肽的羧基末端与叠氮基丙基官能化的MCM-41纳米粒子(固体Ru-tLys-S1)进行特异性连接。一旦合成,由于聚合物α-聚-L-赖氨酸覆盖纳米颗粒表面,两种纳米颗粒在水中显示几乎零的货物释放。相反,由于聚合物酰胺键的水解,在蛋白酶存在下观察到了显着的有效载荷输送。一旦进行化学表征,就对染料在细胞内培养基中的存活率和溶酶体酶控制释放进行了研究。最后,通过制备载有细胞毒性药物喜树碱(CPT),CPT-rLys-S1和CPT-tLys-S1的相应α-聚-L-赖氨酸封端的介孔二氧化硅纳米颗粒,测试了将这些材料用作药物传递系统的可能性。 。研究了细胞摄取和细胞死亡诱导。证明了两种纳米颗粒作为新的潜在癌症治疗平台的效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号